Increased expression of <i>Solute carrier family 12 member 5</i> via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
Lixia Xu(Tianjin Huanhu Hospital), Jun Yu(Yueyang Second People's Hospital), Xin‐Yuan Guan(Sun Yat-sen University), Joseph J.�Y. Sung(Nanyang Technological University), Xiaoxing Li(Sun Yat-sen University), Ka‐Fai To(Chinese University of Hong Kong), William Ka Kei Wu(Quantitative BioSciences), Wei Kang(Chinese University of Hong Kong), Francis K.L. Chan(Chinese University of Hong Kong), Xiangchun Li(Tianjin Medical University Cancer Institute and Hospital), Muyan Cai(Sun Yat-sen University), Joanna H.M. Tong(Chinese University of Hong Kong), Jinna Chen(Southern University of Science and Technology)
Cited by 50
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830